Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link What is the pipeline for future medications for obesity? International Journal of Obesity Peptides for Weight Loss Revolution Health & Wellness PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar retatrutide and cagrilintide 15mg 5mg cagrisema #semaglutide #amylin #glp1 #obesity #dualincretins Yulia Lurye, MD